Skip to content

Silvio E. Inzucchi

Brigham and Women's Hospital

2 papers in the Anchorcite directory, published between 2015 and 2019, cited 20,125 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Bernard Zinman · 1 paper
  • Christoph Wanner · 1 paper
  • John M. Lachin · 1 paper
  • DAVID H. FITCHETT · 1 paper
  • Erich Bluhmki · 1 paper
  • Stefan Hantel · 1 paper
  • Michaela Mattheus · 1 paper
  • Theresa Devins · 1 paper

Papers

  1. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesNew England Journal of Medicine · 2015 · 12,596 citations

    BACKGROUND: The effects of empagliflozin, an inhibitor of sodium-glucose cotransporter 2, in addition to standard care, on cardiovascular morbidity and mortality in patients with type 2 diabetes at high cardiovascular risk are not known. METHODS: We randomly assigned patients to…

  2. Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionNew England Journal of Medicine · 2019 · 7,529 citations

    BACKGROUND: In patients with type 2 diabetes, inhibitors of sodium-glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through glucose-independent mechanisms. More data are needed regarding the effects of SGLT2 inhibitors in patients with…

Metadata from OpenAlex (CC0).